Alethia Young Bicycle Therapeutics PLC (BCYC) insider trading activity

BCYC Quotes by TradingView

Alethia Young is Chief Financial Officer of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 45,605 shares of BCYC, which is worth approximately $591,952. The most recent transaction as insider was on Jan 02, 2025, when has been sold 1,395 shares (Ordinary Shares) at a price of $14.09 per share, resulting in proceeds of $19,655. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.6K
280.04% 3M change
280.04% 12M change
Total Value Held $591,952

Alethia Young Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
SELL
Open market or private sale
$19,655 $14.09 p/Share
1,395 Reduced 2.97%
45,605 Ordinary Shares
Jan 02 2025
BUY
Grant, award, or other acquisition
-
35,000 Added 42.68%
47,000 Ordinary Shares
Jan 02 2024
BUY
Grant, award, or other acquisition
-
12,000 Added 50.0%
12,000 Ordinary Shares

Also insider at

GRPH
Graphite Bio, Inc. Healthcare
Chief Financial Officer
PTCT
PTC THERAPEUTICS, INC. Healthcare
PCRX
Pacira BioSciences, Inc. Healthcare
Director
AY

Alethia Young

Chief Financial Officer
South Plainfield, NJ

Track Institutional and Insider Activities on BCYC

Follow BICYCLE THERAPEUTICS plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

News

Receive news related to BICYCLE THERAPEUTICS plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCYC